维普中文期刊产品整合服务
63篇 您的检索式:作者名="Halank"
    题名 作者 年代 出处 被引量
1Fingolimod in a patient with heart failure on the background of pulmonary arterial hyperten- sion and coronary artery disease显示文摘Thomas K Schrotter H Halank M 2014BMC Neurol2014,14,:1
2Portopulmonary hypertension 显示文摘Halank M Ewart R Seyfarth H J 2006J Gastroentero12006,41,9:1
3Monotherapy versus combination therapy in patients hospitalized with community-acquired pneumonia显示文摘 Halank M Hffken G 2006Treat Respir Med2006,5,:1
4Rio- ciguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase Ⅱ study显示文摘GHOFRANI H A HOEPER M M HALANK M 2010Eur Respir J2010,36,4:1
5Bosentan therapy for portopulmonary hypertension显示文摘Hoeper MM Halank M Marx C 2005Eur Respir J2005,25,3:1
6Portopulmonary hypertension显示文摘Michael Halank Ralf Ewert Hans-Juergen Seyfarth Gert Hoeffken 2006Journal of Gastroenterology2006,,9:1
7Riociguat for chro- nic thromboembolic pulmonary hypertension and pulmonary arteri- al hypertension: a phase II study显示文摘Ghofrani HA Hoeper MM Halank M 2010Eur Respir J2010,36,4:1
8Portopulmonary hypertension显示文摘Halank M Ewert R Seyfarth HS 2006J Gastroenterol2006,41,9:1
9Portopulmonary hypertension显示文摘 Ewert R Seyfarth HJ 2006J Gastroanterol2006,41,:1
10Rioeiguat for intersti- tial lung disease and pulmonary hypertension: a pilot trial显示文摘Hoeper MM Halank M Wilkens H 2013Eur Respir J2013,41,4:1
11Inhalative iloprost- pharmacology and clinical application显示文摘Ewert R Schitper C Halank M 2009Expert Opin Pharmacother2009,10,13:1
12Portopulmonary hypertension显示文摘Michael Halank Ralf Ewert Hans-Juergen Seyfarth Gert Hoeffken 2006Journal of Gastroenterology2006,,9:1
13Portopulmonary hypertension显示文摘 Ewert R Seyfarth HJ 2006J Gastrcenterol2006,41,:1
14Hemoptysis because of pulmonary vein stenosis and occlusion after pulmonary vein isolation for atrial fibrillation 显示文摘Braun S Kolditz M Halank M 2011Dtsch Med Wochens- chr2011,136,13:1
15Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension显示文摘Hoeper M Leuchte H Halank M 2006Eur Respir J2006,28,4:1
16Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study显示文摘Ghofrani HA Hoeper MM Halank M 2010Eur RespirJ2010,36,4:1
17Copeptin predicts clinical deterioration and persistent instability in community - acquired pneumonia 显示文摘KOLDITZ M HALANK M SCHULTE HUBBERT B 2012Rcspir Med2012,106,9:1
18Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension:a phase II study显示文摘Ghofrani HA Hoeper MM Halank M 2010Eur Respir J2010,36,4:1
19Anticoagulation and Survival in Pulmonary Arterial Hypertension: Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)显示文摘Karen M. Olsson Marion Delcroix H. Ardeschir Ghofrani Henning Tiede Doerte Huscher Rudolf Speich Ekkehard Grünig Gerd Staehler Stephan Rosenkranz Michael Halank Matthias Held Tobias J. Lange Juergen Behr Hans Klose Martin Claussen Ralf Ewert Christian F. 2014Circulation2014,,1:1
20Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia 显示文摘Kolditz M Halank M Schulte-Hubbert B 2012Respir Med2012,106,9:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费